Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 98 publications
Anti-CD20 associated enterovirus meningoencephalitis: A narrative review with two illustrative cases.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: April 03, 2026
Relationships between neighborhood deprivation, race, and worsening outcomes among MS patients 55 years of age and older.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: March 23, 2026
Longitudinal modeling of upper extremity function in multiple sclerosis: Associations for clinical and sociodemographic factors.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 27, 2025
Performance of Composite Endpoints Defining Progression Independent of Relapse Activity in Multiple Sclerosis.
Journal: Annals of clinical and translational neurology
Published: May 23, 2025
Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial.
Journal: Neurology
Published: December 03, 2024
A digital version of the nine-hole peg test: Speed may be a more reliable measure of upper-limb disability than completion time in patients with multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 02, 2024
AI-driven reclassification of multiple sclerosis progression.
Journal: Nature medicine
Published: October 29, 2024
Prognostic factors for worsening and improvement in multiple sclerosis using a multistate model.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: September 28, 2024
Subcutaneous ocrelizumab in multiple sclerosis: Results of the Phase 1b OCARINA I study.
Journal: Annals of clinical and translational neurology
Published: August 01, 2024
Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trials.
Journal: Therapeutic advances in neurological disorders
Published: March 05, 2024
A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 20, 2024
Last Updated: 09/26/2026